APOB antibody (AA 592-689)
Quick Overview for APOB antibody (AA 592-689) (ABIN7875926)
Target
See all APOB AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 592-689
-
Purpose
- APOB Antibody / Apolipoprotein B
-
Purification
- Protein G affinity chromatography
-
Immunogen
- A portion of amino acids 592-689 from the human protein was used as the immunogen for the APOB antibody.
-
Isotype
- IgG2b, kappa
-
-
-
-
Application Notes
- Optimal dilution of the APOB antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.2 mg/mL
-
Buffer
- 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced) and 0.05 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store the APOB antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
-
-
- APOB (Apolipoprotein B (APOB))
-
Alternative Name
- APOB
-
Background
- Post-transcriptional editing of apolipoprotein B (apoB) mRNA is regulated by APOBEC1 (also designated human (or rat) small intestinal apolipoprotein B mRNA editing protein, HEPR or REPR) in hepatic cells to achieve a steady state proportion of edited and unedited RNA molecules. Two forms of apoB are known to circulate in the plasma of mammals. ApoB-100 is a protein primarily synthesized in the liver as a structural component of very low density lipoprotein particles. A truncated form of apoB-100, apoB-48, is synthesized in the small intestine and contains the amino-terminal 2,152 amino acids of the larger protein. This organ-specific partitioning of apoB production is the resultof RNA editing of a common apoB gene.
-
UniProt
- P04114
-
Pathways
- Lipid Metabolism
Target
-